Beta-2-agonists in asthma treatment:
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
New York [u.a.]
Dekker
1997
|
| Series: | Lung biology in health and disease
106 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | XVI, 443 S. Ill., graph. Darst. |
| ISBN: | 0824794966 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011437831 | ||
| 003 | DE-604 | ||
| 005 | 20230713 | ||
| 007 | t | ||
| 008 | 970715s1997 ad|| |||| 00||| eng d | ||
| 020 | |a 0824794966 |9 0-8247-9496-6 | ||
| 035 | |a (OCoLC)231703724 | ||
| 035 | |a (DE-599)BVBBV011437831 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-12 | ||
| 084 | |a YB 6415 |0 (DE-625)153148:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Beta-2-agonists in asthma treatment |c ed. by Romain Pauwels ... |
| 246 | 1 | 3 | |a Beta2-agonists in asthma treatment |
| 264 | 1 | |a New York [u.a.] |b Dekker |c 1997 | |
| 300 | |a XVI, 443 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Lung biology in health and disease |v 106 | |
| 650 | 0 | 7 | |a Bronchialasthma |0 (DE-588)4069674-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Beta-Blocker |0 (DE-588)4006088-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Beta-2-Rezeptor |0 (DE-588)4254128-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Adrenerger Rezeptor |0 (DE-588)4000526-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Bronchialasthma |0 (DE-588)4069674-1 |D s |
| 689 | 0 | 1 | |a Adrenerger Rezeptor |0 (DE-588)4000526-4 |D s |
| 689 | 0 | 2 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Bronchialasthma |0 (DE-588)4069674-1 |D s |
| 689 | 1 | 1 | |a Beta-Blocker |0 (DE-588)4006088-3 |D s |
| 689 | 1 | 2 | |a Beta-2-Rezeptor |0 (DE-588)4254128-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Pauwels, Romain |e Sonstige |4 oth | |
| 830 | 0 | |a Lung biology in health and disease |v 106 |w (DE-604)BV000008326 |9 106 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007692168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007692168 | ||
Record in the Search Index
| _version_ | 1804125954007629824 |
|---|---|
| adam_text | BETA 2 -AGONISTS IN ASTHMA TREATMENT EDITED BY ROMAIN PAUWELS UNIVERSITY
HOSPITAL GHENT, BELGIUM PAUL M. O BYRNE MCMASTER UNIVERSITY HAMILTON,
ONTARIO, CANADA :MARCEL DEKKER, INC. NEW YORK * BASEL * HONG KONG
CONTENTS INTRODUCTION CLAUDE LENFANT HI PREFACE V CONTRIBUTORS VII 1. ON
THE HISTORY OF SYMPATHOMIMETICS IN ASTHMA 1 CARL G. A. PERSSON I.
INTRODUCTION 1 II. CURATIVE INFLUENCE OF VIOLENT EMOTION 2 III.
STRESS THERAPIES OF ASTHMA 2 IV. ADRENAL EXTRACT 4 V. ADRENAL
SUBSTANCE 5 VI. ADRENALINE 7 VII. SYMPATHOMIMETICS AND MECHANISMS OF
ASTHMA 8 VIII. LIFE-THREATENING ASTHMA 9 IX. COCAINE AND EPHEDRINE 11 XI
;II CONTENTS X. P-AGONISTS FOR ASTHMA: DRUGS PRECEDE THEORETICAL
DEVELOPMENTS 12 XI. CONCLUSIONS 14 REFERENCES 16 2. MOLECULAR BIOLOGY OF
THE BETA 2 -ADRENERGIC RECEPTOR FOCUS ON INTERACTIONS OF AGONIST WITH
RECEPTOR 19 STEPHEN B. LIGGETT AND STUART A. GREEN I. INTRODUCTION 19
II. FEATURES OF G-PROTEIN-COUPLED RECEPTORS 19 III. STRUCTURE/FUNCTION
RELATIONSHIPS OF P2AR 21 IV. DELINEATING A SPECIFIC SALMETEROL EXOSITE
BINDING MOTIF IN THE P 2 AR 25 V. CONCLUSIONS 32 REFERENCES 32 3. EFFECT
OF BETA-AGONISTS ON AIRWAY EFFECTOR CELLS 35 PETER J. BARNES I.
INTRODUCTION 35 II. AIRWAY SMOOTH MUSCLE . 36 III. AIRWAY NERVES 39 IV.
SECRETORY CELLS 40 V. BLOOD VESSELS 42 VI. INFLAMMATORY CELLS 42 VII.
REGULATION OF AIRWAY P-RECEPTORS 45 VIII. RECEPTOR CROSS-TALK 51
REFERENCES 53 DISCUSSION BERTIL WALDECK 64 4. EFFECTS OF BETAF-AGONISTS
ON AIRWAY INFLAMMATION 67 PETER HOWARTH I. II. III. IV. V. INTRODUCTION
MUCOSAL INFLAMMATION AND ASTHMA P2-AGONIST-MEDIATED EFFECTS RELEVANT TO
ASTHMATIC INFLAMMATION IN VITRO STUDIES CONCLUSIONS REFERENCES
DISCUSSION RONALD DAHL 67 68 70 71 75 77 84 CONTENTS XIII 5.
PHARMACOKINETICS OF BETA 2 -ADRENOCEPTOR-STIMULATING DRUGS 87 LARS
NYBERG I. II. III. IV. V. VI. INTRODUCTION ANALYTICAL METHODS ROUTES OF
ADMINISTRATION COMMON PHARMACOKINETIC CHARACTERISTICS OF P2-AGONISTS
PHARMACOKINETICS OF INDIVIDUAL P 2 -AGONISTS CONCLUSIONS REFERENCES 87
89 90 94 102 111 111 6. MECHANISMS OF DURATION OF ACTION OF INHALED
LONG-ACTING BETA 2 -ADRENOCEPTOR AGONISTS 131 KLAUS F. RABE AND ANDERS
LINDEN I. II. III. IV. V. VI. VII. VIII. INTRODUCTION PHYSICOCHEMICAL
PROPERTIES OF FORMOTEROL AND SALMETEROL ANIMAL AIRWAYS HUMAN AIRWAYS
HYPOTHESIS ON LONG DURATION OF ACTION INTERACTIONS WITH THE CELL
MEMBRANE OF AIRWAY SMOOTH MUSCLE ROLE OF NON-P-ADRENOCEPTOR-MEDIATED
RELAXATION? CONCLUSIONS REFERENCES DISCUSSION GARY P. ANDERSON 131 132
132 142 147 149 151 152 152 156 7. BRONCHODILATATION 161 ERIC DEROM AND
ROMAIN PAUWELS I. INTRODUCTION 161 II. MECHANISMS UNDERLYING THE
BRONCHODILATING ACTION 162 III. ORAL AND PARENTERAL ADMINISTRATION OF
P2-AGONISTS 162 IV. INHALATION OF P 2 -AGONISTS 164 V. COMPARISON
BETWEEN BRONCHODILATING CAPACITY OF P2-AGONISTS AND OTHER
BRONCHODILATING DRUGS 169 VI. COMBINATION OF SHORT-ACTING P2-AGONISTS
WITH OTHER DRUGS 169 REFERENCES 171 DISCUSSION DIRKJE S. POSTMA 176 XIV
CONTENTS 8. EFFECTS OF BETA 2 -AGONISTS ON AIRWAY RESPONSIVENESS AND
ALLERGEN-INDUCED RESPONSES 179 10. PAULM. I. II. III. IV. V. VI. VII.
VIII. O BYRNE INTRODUCTION AIRWAY HYPERRESPONSIVENESS IN ASTHMA EFFECTS
OF INHALED P2-AGONISTS ON AIRWAY RESPONSIVENESS ALLERGEN-INDUCED AIRWAY
RESPONSES EFFECTS OF P 2 -AGONISTS ON ALLERGEN-INDUCED RESPONSES EFFECTS
OF REGULAR USE OF INHALED P2-AGONISTS TACHYPHYLAXIS TO FUNCTIONAL
ANTAGONISM CONCLUSIONS REFERENCES DISCUSSION ERIC DEROM 179 180 181 183
184 186 187 188 188 192 9. EFFECT OF BETA-ADRENERGIC AGONISTS ON COUGH
AND MUCOCILIARY CLEARANCE 197 KIAN FAN CHUNG I. II. III. COUGH
MUCOCILIARY CLEARANCE CONCLUSIONS REFERENCES DISCUSSION JAN-ANDERS
KARLSSON INHALATION TECHNIQUE AND INHALATION DEVICES MYRNA I. II. III.
IV. V. VI. DOLOVICH INTRODUCTION PHYSICAL CHARACTERISTICS OF AEROSOLS
COMPONENTS OF THE INHALATION TECHNIQUE METHODS TO IMPROVE INHALATION
TECHNIQUE PATIENT INSTRUCTION IN THE USE OF INHALERS CONCLUSIONS
REFERENCES DISCUSSION LARS BORGSTROM 197 205 211 212 222 229 229 231 232
237 246 246 246 252 11. ADVERSE EFFECTS OF BETA 2 -AGONISTS 257 CARLD.
BURGESS, RICHARD BEASLEY, JULIAN CRANE, AND NEIL PEARCE I. INTRODUCTION
257 II. ACUTE PHARMACOLOGICAL CHANGES 258 CONTENTS XV III. ASTHMA
MORTALITY AND INHALED P-AGONISTS 258 IV. CHRONIC ADVERSE EFFECTS:
INCREASE IN ASTHMA SEVERITY 266 V. CONCLUSIONS 272 REFERENCES 272
DISCUSSION KENNETH R. CHAPMAN 276 12. CLINICAL STUDIES OF BETA-AGONISTS
IN ADULTS 283 A. E. TATTERSFIELD I. INTRODUCTION 283 II. SHORTER-ACTING
P-AGONISTS 284 III. LONGER-ACTING P-AGONISTS 292 IV. CONCLUSIONS 298
REFERENCES 300 DISCUSSION MALCOLM R. SEARS 305 DISCUSSION KENNETH R.
CHAPMAN 312 13. CLINICAL STUDIES OF BETA 2 -ADRENERGIC AGONISTS IN
CHILDREN 319 F. ESTELLE R. SIMONS I. II. III. IV. V. INTRODUCTION
CHRONIC ASTHMA ACUTE ASTHMA ADDITIONAL SAFETY ISSUES REGARDING P 2
-ADRENERGIC AGONISTS IN CHILDREN CONCLUSIONS REFERENCES DISCUSSION
ANDREA VON BERG 319 322 330 334 335 336 342 14. TOLERANCE WITH BETA 2
-AGONISTS: A CLINICAL PROBLEM? 349 BRIAN JONATHON LIPWORTH I.
INTRODUCTION , 349 II. REQUISITES FOR CLINICAL STUDIES 350 III. STUDIES
WITH SHORT-ACTING P 2 -AGONISTS 350 IV. STUDIES WITH LONG-ACTING P 2
-AGONISTS 352 V. CONCLUSIONS 358 REFERENCES 360 DISCUSSION PETER J.
STERK 361 XVI CONTENTS 15. ROLE OF BETA 2 -AGONISTS IN THE TREATMENT OF
ASTHMA IN ADULTS 367 ROMAIN PAUWELS I. INTRODUCTION 367 II. INHALED
SYMPATHOMIMETICS IN THE CHRONIC TREATMENT OF ASTHMA 367 III. INHALED
SYMPATHOMIMETICS IN THE TREATMENT OF ACUTE ACUTE SEVERE ASTHMA 370 IV.
PLACE OF ORAL P 2 -AGONISTS IN THE TREATMENT OF ASTHMA 371 REFERENCES
371 DISCUSSION ALBERT L. SHEFFER 373 16. THE ROLE OF BETA 2 -AGONISTS IN
THE TREATMENT OF ASTHMA IN CHILDREN 379 379 380 383 384 385 386 387 387
392 397 437 S0REN PEDERSEN I. II. III. IV. V. VI. VII. AUTHOR INDEX
SUBJECT INDEX INTRODUCTION ACUTE SEVERE ASTHMA REVERSAL OF ACUTE
BRONCHOCONSTRICTION INHIBITION OF ACUTE BRONCHOCONSTRICTION CHRONIC
TREATMENT OF SYMPTOMS MODES OF ADMINISTRATION CONCLUSIONS REFERENCES
DISCUSSION JAMES P. KEMP
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV011437831 |
| classification_rvk | YB 6415 |
| ctrlnum | (OCoLC)231703724 (DE-599)BVBBV011437831 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01967nam a2200481 cb4500</leader><controlfield tag="001">BV011437831</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20230713 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970715s1997 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824794966</subfield><subfield code="9">0-8247-9496-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231703724</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011437831</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YB 6415</subfield><subfield code="0">(DE-625)153148:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Beta-2-agonists in asthma treatment</subfield><subfield code="c">ed. by Romain Pauwels ...</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Beta2-agonists in asthma treatment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 443 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Lung biology in health and disease</subfield><subfield code="v">106</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bronchialasthma</subfield><subfield code="0">(DE-588)4069674-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Beta-2-Rezeptor</subfield><subfield code="0">(DE-588)4254128-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Adrenerger Rezeptor</subfield><subfield code="0">(DE-588)4000526-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Bronchialasthma</subfield><subfield code="0">(DE-588)4069674-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Adrenerger Rezeptor</subfield><subfield code="0">(DE-588)4000526-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Bronchialasthma</subfield><subfield code="0">(DE-588)4069674-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Beta-2-Rezeptor</subfield><subfield code="0">(DE-588)4254128-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pauwels, Romain</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Lung biology in health and disease</subfield><subfield code="v">106</subfield><subfield code="w">(DE-604)BV000008326</subfield><subfield code="9">106</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007692168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007692168</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV011437831 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:09:45Z |
| institution | BVB |
| isbn | 0824794966 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007692168 |
| oclc_num | 231703724 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 |
| owner_facet | DE-355 DE-BY-UBR DE-12 |
| physical | XVI, 443 S. Ill., graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Dekker |
| record_format | marc |
| series | Lung biology in health and disease |
| series2 | Lung biology in health and disease |
| spelling | Beta-2-agonists in asthma treatment ed. by Romain Pauwels ... Beta2-agonists in asthma treatment New York [u.a.] Dekker 1997 XVI, 443 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Lung biology in health and disease 106 Bronchialasthma (DE-588)4069674-1 gnd rswk-swf Beta-Blocker (DE-588)4006088-3 gnd rswk-swf Beta-2-Rezeptor (DE-588)4254128-1 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Adrenerger Rezeptor (DE-588)4000526-4 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Bronchialasthma (DE-588)4069674-1 s Adrenerger Rezeptor (DE-588)4000526-4 s Therapie (DE-588)4059798-2 s DE-604 Beta-Blocker (DE-588)4006088-3 s Beta-2-Rezeptor (DE-588)4254128-1 s Pauwels, Romain Sonstige oth Lung biology in health and disease 106 (DE-604)BV000008326 106 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007692168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Beta-2-agonists in asthma treatment Lung biology in health and disease Bronchialasthma (DE-588)4069674-1 gnd Beta-Blocker (DE-588)4006088-3 gnd Beta-2-Rezeptor (DE-588)4254128-1 gnd Therapie (DE-588)4059798-2 gnd Adrenerger Rezeptor (DE-588)4000526-4 gnd |
| subject_GND | (DE-588)4069674-1 (DE-588)4006088-3 (DE-588)4254128-1 (DE-588)4059798-2 (DE-588)4000526-4 (DE-588)4143413-4 |
| title | Beta-2-agonists in asthma treatment |
| title_alt | Beta2-agonists in asthma treatment |
| title_auth | Beta-2-agonists in asthma treatment |
| title_exact_search | Beta-2-agonists in asthma treatment |
| title_full | Beta-2-agonists in asthma treatment ed. by Romain Pauwels ... |
| title_fullStr | Beta-2-agonists in asthma treatment ed. by Romain Pauwels ... |
| title_full_unstemmed | Beta-2-agonists in asthma treatment ed. by Romain Pauwels ... |
| title_short | Beta-2-agonists in asthma treatment |
| title_sort | beta 2 agonists in asthma treatment |
| topic | Bronchialasthma (DE-588)4069674-1 gnd Beta-Blocker (DE-588)4006088-3 gnd Beta-2-Rezeptor (DE-588)4254128-1 gnd Therapie (DE-588)4059798-2 gnd Adrenerger Rezeptor (DE-588)4000526-4 gnd |
| topic_facet | Bronchialasthma Beta-Blocker Beta-2-Rezeptor Therapie Adrenerger Rezeptor Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007692168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000008326 |
| work_keys_str_mv | AT pauwelsromain beta2agonistsinasthmatreatment |